The PE Ratio as of December 2025 (TTM) for Phathom Pharmaceuticals, Inc. (PHAT) is -3.91

According to Phathom Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.91. This represents a change of 23.83% compared to the average of -3.16 of the last 4 quarters.

Phathom Pharmaceuticals, Inc. (PHAT) Historical PE Ratio (quarterly & annually)

How has PHAT PE Ratio performed in the past?

The mean historical PE Ratio of Phathom Pharmaceuticals, Inc. over the last ten years is -26.65. The current -3.91 PE Ratio has changed 1.37% with respect to the historical average. Over the past ten years (40 quarters), PHAT's PE Ratio was at its highest in in the June 2019 quarter at -0.60. The PE Ratio was at its lowest in in the September 2018 quarter at -181.92.

Phathom Pharmaceuticals, Inc. (PHAT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Phathom Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Phathom Pharmaceuticals, Inc. (PHAT) Average PE Ratio

How has PHAT PE Ratio performed in the past?

The current PE Ratio of Phathom Pharmaceuticals, Inc. (PHAT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Phathom Pharmaceuticals, Inc. (PHAT) PE Ratio vs. Peers

How is PHAT’s PE Ratio compared to its peers?

Phathom Pharmaceuticals, Inc.’s PE Ratio is greater than Nurix Therapeutics, Inc. (-6.20), greater than Kodiak Sciences Inc. (-8.40), greater than Xencor, Inc. (-7.58), greater than UroGen Pharma Ltd. (-7.48), greater than Bicara Therapeutics Inc. Common Stock (-9.97), greater than Oculis Holding AG (-7.70), less than BridgeBio Oncology Therapeutics Inc. (-2.36), greater than Septerna, Inc. (-19.73), greater than Sana Biotechnology, Inc. (-4.90), greater than AnaptysBio, Inc. (-14.24),

Build a custom stock screener for Phathom Pharmaceuticals, Inc. (PHAT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phathom Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Phathom Pharmaceuticals, Inc. (PHAT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Phathom Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.